FELINE GENOME EDITING WITH ZINC FINGER NUCLEASES

• US 20110023156A1
• Filed: 07/23/2010
• Published: 01/27/2011
• Est. Priority Date: 12/04/2008
• Status: Abandoned Application

• Current Assignee: Sigma-Aldrich Company (Sigma-Aldrich Corporation)
• Original Assignee: Sigma-Aldrich Company (Sigma-Aldrich Corporation)
• Inventors: Miller, Shondra, Davis, Gregory, Buntaine, Brian, Cui, Xiaoxia, Bedell, Joseph
• Application Number:
  US12/842,219
• Publication Number:
  US 20110023156A1
• Time in Patent Office: Days
• US Class Current: 800/14
• CPC Class Codes: A01K 2227/10 Mammal
• CPC Class Codes: A01K 2267/02 Animal zootechnically ameliorated
• CPC Class Codes: A01K 67/0276 Knock-out vertebrates
• CPC Class Codes: C12N 15/8509 for producing genetically modified animals, e.g. transgenic
• CPC Class Codes: C12N 2800/80 Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113

Abstract

The present invention provides a genetically modified feline or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the feline genome.

Claims

1. A genetically modified feline comprising at least one edited chromosomal sequence.

2. The genetically modified feline of claim 1, wherein the edited chromosomal sequence is inactivated, is modified, or has an integrated sequence.

3. The genetically modified feline of claim 1, wherein the edited chromosomal sequence encodes a protein chosen from Felis domesticus 1 (Fel d1), tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), augoti signaling protein (ASIP), melanophilin (MLPH), fibroblast growth factor 5 (FGF5), cauxin, and combinations thereof.

4. The genetically modified feline of claim 3, wherein the protein is Fel d1, and the edited chromosomal sequence comprises at least one mutation in at least one of its chains such that the sequence is inactivated and no functional protein is produced.

5. The genetically modified feline of claim 4, wherein the feline is hypoallergenic.

6. The genetically modified feline of claim 3, wherein the protein is TYR, and the edited chromosomal sequence comprises at least one mutation such that the sequence is modified and the expressed protein comprises at least one amino acid change.

7. The genetically modified feline of claim 6, wherein the feline has a different coat color, coat pattern, and/or eye color than a feline in which the chromosomal region is not edited.

8. The genetically modified feline of claim 6, wherein the feline comprises a Burmese or Siamese phenotype.

9. The genetically modified feline of claim 3, wherein the protein is TYRP1, ASIP, or MLPH, and the edited chromosomal sequence comprises at least one mutation such that the sequence is modified or inactivated.

10. The genetically modified feline of claim 9, wherein the feline has a different coat color, coat pattern, and/or eye color than a feline in which the chromosomal region is not edited.

11. The genetically modified feline of claim 3, wherein the protein is FGF5, and the edited chromosomal sequence comprises at least one mutation such that the sequence is modified and the expressed protein comprises at least one amino acid change.

12. The genetically modified feline of claim 11, wherein the feline has a different hair phenotype than a feline in which the chromosomal sequence is not edited.

13. The genetically modified feline of claim 3, wherein the protein is cauxin, and the edited chromosomal sequence comprises at least one mutation such that the sequence is inactivated and no functional protein is produced.

14. The genetically modified feline of claim 13, wherein the feline does not excrete felinine or felinine-related compounds.

15. The genetically modified feline of claim 1, wherein the feline is heterozygous or homozygous for the edited chromosomal sequence.

16. The genetically modified feline of claim 1, wherein the feline is a domestic cat.

17. The genetically modified feline of claim 1, wherein the feline is an embryo, a kitten, a juvenile, or an adult.

18. A feline embryo, the embryo comprising at least one RNA molecule encoding a zinc finger nuclease that is able to cleave a site in the chromosomal sequence, and, optionally, (i) at least one donor polynucleotide comprising a sequence that is flanked by an upstream sequence and a downstream sequence, the upstream and downstream sequences having substantial sequence identity with either side of the site of cleavage or (ii) at least one exchange polynucleotide comprising a sequence that is substantially identical to a portion of the chromosomal sequence at the site of cleavage and which further comprises at least one nucleotide change.

19. The feline embryo of claim 18, wherein the chromosomal sequence encodes a protein chosen from Felis domesticus 1 (Fel d1), tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), augoti signaling protein (ASIP), melanophilin (MLPH), fibroblast growth factor 5 (FGF5), cauxin, and combinations thereof.

20. A genetically modified feline cell comprising at least one edited chromosomal sequence.

21. The genetically modified feline cell of claim 20, wherein the edited chromosomal sequence encodes a protein chosen from Felis domesticus 1 (Fel d1), tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), augoti signaling protein (ASIP), melanophilin (MLPH), fibroblast growth factor 5 (FGF5), cauxin, and combinations thereof.

22. The genetically modified feline cell of claim 20, wherein the protein is chosen from Fel d1, TYRP1, ASIP, MLPH, FGF5, cauxin, and combinations thereof, and the edited chromosomal sequence comprises at least one mutation such that the sequence is inactivated and no functional protein is produced.

23. The genetically modified feline cell of claim 20, wherein the protein is chosen from TYR, TYRP1, ASIP, MLPH, and FGF5, and combinations thereof, and the edited chromosomal sequence comprises at least one mutation such that the sequence is modified and the expressed protein comprises at least one amino acid change.

24. The genetically modified feline cell of claim 20, wherein the cell is heterozygous or homozygous for the edited chromosomal sequence.

25. The genetically modified feline cell of claim 20, wherein the cell is derived from a domestic cat.

26. A zinc finger nuclease, the zinc finger nuclease comprising a zinc finger DNA binding domain and a cleavage domain, the zinc finger nuclease having an amino acid sequence that has at least about 80% sequence identity to a sequence chosen from SEQ ID NOs:

1, 2, 3, 4, 5, 6, 7, and 8, or the zinc finger DNA binding domain helices have an amino acid sequence that is at least about 80% identical to a sequence chosen from SEQ ID NOs;

19, 20, 21, 22, 23, 24, 25, and 26.

27. The zinc finger nuclease of claim 26, wherein the sequence identity is at least about 85%, 90%, 95%, or 100%.

28. The zinc finger nuclease of claim 26, wherein the DNA binding domain comprises at least three zinc finger recognition regions.

29. The zinc finger nuclease of claim 26, wherein the DNA binding domain binds a chromosomal sequence having at least about 80% sequence identity to a sequence chosen from SEQ ID NOs:

9, 10, 11, 12, 13, 14, 15, 16, 27, 28, 29, 30, 31, 32, 33, and 34.

31. The zinc finger nuclease of claim 26, wherein the cleavage domain is a wild-type or an engineered FokI cleavage domain.

30. The zinc finger nuclease of claim 36, wherein the sequence identity is at least about 85%, 90%, 95%, or 100%.

32. A nucleic acid sequence bound by a zinc finger nuclease, the nucleic acid sequence having at least 80% sequence identity with a sequence chosen from SEQ ID NOs:

9, 10, 11, 12, 13, 14, 15, 16, 27, 28, 29, 30, 31, 32, 33, and 34.

33. The nucleic acid sequence of claim 32, wherein the sequence identity is at least about 85%, 90%, 95%, or 100%.